HK1120823A1 - Safflower with elevated gamma linolenic acid - Google Patents
Safflower with elevated gamma linolenic acidInfo
- Publication number
- HK1120823A1 HK1120823A1 HK08108949.7A HK08108949A HK1120823A1 HK 1120823 A1 HK1120823 A1 HK 1120823A1 HK 08108949 A HK08108949 A HK 08108949A HK 1120823 A1 HK1120823 A1 HK 1120823A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- safflower
- linolenic acid
- gamma linolenic
- elevated gamma
- elevated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- C12N9/0083—Miscellaneous (1.14.99)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- General Engineering & Computer Science (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Nutrition Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physics & Mathematics (AREA)
- Diabetes (AREA)
- Plant Pathology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68413405P | 2005-05-23 | 2005-05-23 | |
US73598405P | 2005-11-10 | 2005-11-10 | |
PCT/US2006/020047 WO2006127789A2 (fr) | 2005-05-23 | 2006-05-22 | Safran a teneur elevee en acide gamma-linolenique |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1120823A1 true HK1120823A1 (en) | 2009-04-09 |
Family
ID=37452775
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK08108949.7A HK1120823A1 (en) | 2005-05-23 | 2008-08-13 | Safflower with elevated gamma linolenic acid |
Country Status (13)
Country | Link |
---|---|
US (2) | US7893321B2 (fr) |
EP (1) | EP1885862B1 (fr) |
JP (1) | JP5033122B2 (fr) |
CN (1) | CN101321872B (fr) |
AR (1) | AR053477A1 (fr) |
AU (1) | AU2006249983B2 (fr) |
BR (1) | BRPI0611480B1 (fr) |
CA (1) | CA2609367C (fr) |
CL (1) | CL2007003413A1 (fr) |
ES (1) | ES2550623T3 (fr) |
HK (1) | HK1120823A1 (fr) |
NZ (1) | NZ563676A (fr) |
WO (1) | WO2006127789A2 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1831380A2 (fr) * | 2004-12-20 | 2007-09-12 | BASF Plant Science GmbH | Molecules d'acide nucleique codant pour des genes de desaturase d'acides gras provenant de plantes et leurs procedes d'utilisation |
CN101516181B (zh) | 2006-07-14 | 2015-09-30 | 联邦科学技术研究组织 | 改变水稻的脂肪酸组成 |
JP2011519552A (ja) * | 2008-04-25 | 2011-07-14 | ビーエーエスエフ プラント サイエンス ゲーエムベーハー | 植物種子油 |
CN102171345B (zh) * | 2008-08-01 | 2013-09-25 | 纳幕尔杜邦公司 | Δ6去饱和酶及其在制备多不饱和脂肪酸中的用途 |
NZ631696A (en) | 2012-04-25 | 2017-02-24 | Grains Res & Dev Corp | High oleic acid oils |
US8816111B2 (en) | 2012-06-15 | 2014-08-26 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising polyunsaturated fatty acids |
WO2015087058A1 (fr) * | 2013-12-10 | 2015-06-18 | The University Of York | Acides nucléiques et polypeptides de désaturases |
CN104726473B (zh) | 2013-12-18 | 2020-02-14 | 联邦科学技术研究组织 | 包含二十二碳六烯酸的提取的植物脂质 |
CN105219789B (zh) | 2014-06-27 | 2023-04-07 | 联邦科学技术研究组织 | 包含二十二碳五烯酸的提取的植物脂质 |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5034322A (en) | 1983-01-17 | 1991-07-23 | Monsanto Company | Chimeric genes suitable for expression in plant cells |
US4743548A (en) | 1984-09-25 | 1988-05-10 | Calgene, Inc. | Plant cell microinjection technique |
US4943674A (en) | 1987-05-26 | 1990-07-24 | Calgene, Inc. | Fruit specific transcriptional factors |
US5420034A (en) | 1986-07-31 | 1995-05-30 | Calgene, Inc. | Seed-specific transcriptional regulation |
US5068193A (en) | 1985-11-06 | 1991-11-26 | Calgene, Inc. | Novel method and compositions for introducing alien DNA in vivo |
US4795855A (en) | 1985-11-14 | 1989-01-03 | Joanne Fillatti | Transformation and foreign gene expression with woody species |
US5188958A (en) | 1986-05-29 | 1993-02-23 | Calgene, Inc. | Transformation and foreign gene expression in brassica species |
US5565347A (en) | 1986-06-10 | 1996-10-15 | Calgene, Inc. | Transformation and foreign gene expression with plant species |
ATE316144T1 (de) | 1987-10-20 | 2006-02-15 | Bayer Bioscience Nv | 5'-flankierende region eines genes von arabidopsis, das für einen 2s albumin-prekursor kodiert |
US5614395A (en) | 1988-03-08 | 1997-03-25 | Ciba-Geigy Corporation | Chemically regulatable and anti-pathogenic DNA sequences and uses thereof |
US5565346A (en) | 1988-07-27 | 1996-10-15 | Calgene, Inc. | Transformation and regeneration system for legumes |
US5106739A (en) | 1989-04-18 | 1992-04-21 | Calgene, Inc. | CaMv 355 enhanced mannopine synthase promoter and method for using same |
US5175095A (en) | 1989-07-19 | 1992-12-29 | Calgene, Inc. | Ovary-tissue transcriptional factors |
ES2033193B1 (es) | 1990-10-30 | 1994-01-16 | Ganadera Union Ind Agro | Mezcla grasa para nutricion infantil y de adultos. |
US5614393A (en) | 1991-10-10 | 1997-03-25 | Rhone-Poulenc Agrochimie | Production of γ-linolenic acid by a Δ6-desaturase |
PH31293A (en) | 1991-10-10 | 1998-07-06 | Rhone Poulenc Agrochimie | Production of y-linolenic acid by a delta6-desaturage. |
US6355861B1 (en) | 1991-10-10 | 2002-03-12 | Rhone-Poulenc Agrochimie | Production of gamma linolenic acid by a Δ6-desaturase |
DE69332538T2 (de) | 1992-04-02 | 2003-11-06 | Sembiosys Genetics Inc | Cis elemente des ölkörperproteins als regulationische signale |
US5539092A (en) | 1992-10-02 | 1996-07-23 | Arch Development Corporation | Cyanobacterial and plant acetyl-CoA carboxylase |
CA2156720A1 (fr) | 1993-02-26 | 1994-09-01 | Jean C. Kridl | Systeme d'expression de gene a base de geminivirus |
US5968809A (en) | 1997-04-11 | 1999-10-19 | Abbot Laboratories | Methods and compositions for synthesis of long chain poly-unsaturated fatty acids |
US6075183A (en) | 1997-04-11 | 2000-06-13 | Abbott Laboratories | Methods and compositions for synthesis of long chain poly-unsaturated fatty acids in plants |
US6432684B1 (en) | 1997-04-11 | 2002-08-13 | Abbott Laboratories | Human desaturase gene and uses thereof |
US6051754A (en) | 1997-04-11 | 2000-04-18 | Abbott Laboratories | Methods and compositions for synthesis of long chain poly-unsaturated fatty acids in plants |
JP4087460B2 (ja) * | 1997-04-11 | 2008-05-21 | カルジーン エル エル シー | 植物における長鎖多不飽和脂肪酸の合成のための方法および組成物 |
US5972664A (en) | 1997-04-11 | 1999-10-26 | Abbott Laboratories | Methods and compositions for synthesis of long chain poly-unsaturated fatty acids |
EP0975765B1 (fr) * | 1997-04-15 | 2006-10-11 | Commonwealth Scientific And Industrial Research Organisation | Genes d'epoxygenase vegetale d'acide gras et utilisation de ces genes |
ES2276475T5 (es) | 1997-09-30 | 2014-07-11 | The Regents Of The University Of California | Producción de proteínas en semillas de plantas |
US6653530B1 (en) * | 1998-02-13 | 2003-11-25 | Calgene Llc | Methods for producing carotenoid compounds, tocopherol compounds, and specialty oils in plant seeds |
US6492108B1 (en) | 1998-03-26 | 2002-12-10 | Incyte Genomics, Inc. | Delta-6 desaturase homologs |
PT1086236E (pt) * | 1998-06-12 | 2007-12-12 | Calgene Llc | Ácidos gordos poliinsaturados em plantas |
US6403349B1 (en) * | 1998-09-02 | 2002-06-11 | Abbott Laboratories | Elongase gene and uses thereof |
US6677145B2 (en) * | 1998-09-02 | 2004-01-13 | Abbott Laboratories | Elongase genes and uses thereof |
US6342657B1 (en) | 1999-05-06 | 2002-01-29 | Rhone-Poulenc Agro | Seed specific promoters |
ATE334206T1 (de) * | 1999-06-07 | 2006-08-15 | Basf Plant Science Gmbh | Delta6-acetylenase und delta6-desaturase aus ceratodon purpureus |
US6815579B1 (en) * | 1999-07-22 | 2004-11-09 | The University Of British Columbia | Plant long chain fatty acid biosynthetic enzyme |
US6777591B1 (en) | 1999-08-27 | 2004-08-17 | Sembiosys Genetics Inc. | Legume-like storage protein promoter isolated from flax and methods of expressing proteins in plant seeds using the promoter |
KR20020073580A (ko) * | 2000-02-09 | 2002-09-27 | 바스프 악티엔게젤샤프트 | 신규 연장효소 유전자 및 다가불포화 지방산의 제조 방법 |
DE10102337A1 (de) * | 2001-01-19 | 2002-07-25 | Basf Plant Science Gmbh | Verfahren zur Herstellung mehrfach ungesättigter Fettsäuren, neue Biosynthesegene sowie neue pflanzliche Expressionskonstrukte |
JP4347572B2 (ja) | 2001-01-25 | 2009-10-21 | アボット・ラボラトリーズ | デサチュラーゼ遺伝子とその使用 |
US6635451B2 (en) | 2001-01-25 | 2003-10-21 | Abbott Laboratories | Desaturase genes and uses thereof |
ES2304455T3 (es) * | 2001-09-05 | 2008-10-16 | Monsanto Technology Llc | Promotor 7s alfa especifico de la semilla para expresion de los genes en las plantas. |
AR044803A1 (es) | 2003-06-17 | 2005-10-05 | Sembiosys Genetics Inc | Metodos para la produccion de insulina |
EP2169053B1 (fr) * | 2003-08-01 | 2015-09-09 | BASF Plant Science GmbH | Procédé de fabrication d'acides gras insaturés de manière multiple dans des organismes transgéniques |
-
2006
- 2006-05-22 AR ARP060102090A patent/AR053477A1/es active IP Right Grant
- 2006-05-22 US US11/438,951 patent/US7893321B2/en active Active
- 2006-05-22 CN CN2006800243596A patent/CN101321872B/zh active Active
- 2006-05-22 AU AU2006249983A patent/AU2006249983B2/en active Active
- 2006-05-22 WO PCT/US2006/020047 patent/WO2006127789A2/fr active Application Filing
- 2006-05-22 ES ES06771043.4T patent/ES2550623T3/es active Active
- 2006-05-22 CA CA2609367A patent/CA2609367C/fr active Active
- 2006-05-22 NZ NZ563676A patent/NZ563676A/en unknown
- 2006-05-22 BR BRPI0611480A patent/BRPI0611480B1/pt active IP Right Grant
- 2006-05-22 EP EP06771043.4A patent/EP1885862B1/fr active Active
- 2006-05-22 JP JP2008513656A patent/JP5033122B2/ja active Active
-
2007
- 2007-11-28 CL CL200703413A patent/CL2007003413A1/es unknown
-
2008
- 2008-08-13 HK HK08108949.7A patent/HK1120823A1/xx unknown
-
2011
- 2011-02-11 US US13/025,345 patent/US8192964B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN101321872B (zh) | 2012-09-05 |
ES2550623T3 (es) | 2015-11-11 |
BRPI0611480B1 (pt) | 2016-06-07 |
NZ563676A (en) | 2011-01-28 |
BRPI0611480A2 (pt) | 2010-09-14 |
US8192964B2 (en) | 2012-06-05 |
US20070067870A1 (en) | 2007-03-22 |
JP5033122B2 (ja) | 2012-09-26 |
CN101321872A (zh) | 2008-12-10 |
WO2006127789A9 (fr) | 2012-03-01 |
AR053477A1 (es) | 2007-05-09 |
CL2007003413A1 (es) | 2008-07-25 |
US7893321B2 (en) | 2011-02-22 |
US20110129428A1 (en) | 2011-06-02 |
AU2006249983A1 (en) | 2006-11-30 |
WO2006127789A3 (fr) | 2007-11-29 |
EP1885862A4 (fr) | 2009-02-25 |
JP2008545411A (ja) | 2008-12-18 |
WO2006127789A2 (fr) | 2006-11-30 |
CA2609367C (fr) | 2014-08-19 |
AU2006249983B2 (en) | 2011-03-17 |
CA2609367A1 (fr) | 2006-11-30 |
EP1885862A2 (fr) | 2008-02-13 |
EP1885862B1 (fr) | 2015-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1120823A1 (en) | Safflower with elevated gamma linolenic acid | |
ZA200709985B (en) | Transesterification methods | |
GB2413280B (en) | Playpen with columns | |
ZA200607333B (en) | Plants modified with mini-chromosomes | |
EP1873487A4 (fr) | Niveau | |
ZA200710460B (en) | Winch | |
GB0506614D0 (en) | An anchor support | |
GB2432116B (en) | Pool | |
EP1917411A4 (fr) | Dispositif de manipulation de montant | |
PL1688672T3 (pl) | Konstrukcja wsporcza | |
PL1907247T3 (pl) | Dźwignik podporowy | |
HK1208777A1 (en) | Near reverse breeding | |
GB0503918D0 (en) | Cell | |
ZA200609892B (en) | Lifting anchor support | |
EP1891467A4 (fr) | Microcolonne a structure simple | |
GB2440700B (en) | Lifting anchor | |
ZA200707290B (en) | Near reverse breeding | |
AU305473S (en) | Support | |
GB0509852D0 (en) | Safe line anchor | |
GB0717348D0 (en) | A temporary fence. A support for a temporary fence and a stabilizing member for use with a temporary fence support. | |
EP1888085A4 (fr) | Procedes offrant des soins palliatifs a base de avr118 | |
GB0505116D0 (en) | Level | |
GB2426528B (en) | The well pond | |
HK1081803A2 (en) | Flag-blowing flagpole | |
GB0605591D0 (en) | Support |